Babycue develops rapid, affordable diagnostic kits to detect and differentiate childhood diarrhea, helping doctors save lives while reducing unnecessary antibiotic use and antimicrobial resistance.
Founders
Dr. Swati Sagarika Panda | Mr. Manish Kumar Swain
Healthcare / MedTech Diagnostics
The Problem:
Childhood diarrhea causes 525,000 deaths yearly, including 300 daily in India. Poor sanitation, unsafe water, and antibiotic misuse worsen the crisis. Early diagnostics are vital for accurate, targeted treatment.
The Solution:
We developed a rapid LFA test for children under 5 to differentiate bacterial vs. non-bacterialdiarrhea, improving treatment andreducing AMR.
Who Benefits?
Pediatric healthcare professionals and hospitals.
Children under 5 & families in India & SAARC with limited time.
Govt & diagnostic programs on AMR reduction.
Key Achievements
Patent published(PCT/IB2023/052710).
- Trials at majorhospitals.
Pilot orders:1300(Dantewada),1500 (Mild Cares).
Clinical trials at ESIC Hospital, Hyderabad and KIMS Hospital,Bhubaneswar
- Grants from BIRAC,SBI Foundation, Pfizer, etc
- Awards: COEP BHAU 2025, and TATA TCS Thematic Winner
Societal Impact
Reduces unnecessary antibiotic use, improves rural diagnostic access, lowers family healthcare costs, empowers frontline workers with rapid tools, reduces hospitalburden, and strengthens child health systems.
Vision for the Future
Year 1: Distribution expansion in India, regulatory clearances.
Year 2: Enter SAARC, scale up manufacturing.
Year 3: Advanced tech upgrades, new diagnostics lines.
